Vita Life Sciences Limited (ASX:VLS)

Market Cap	135.41M +24.8%
Revenue (ttm)	93.27M +17.3%
Net Income	10.44M +18.8%
EPS	0.18 +16.2%
Shares Out	54.38M
PE Ratio	13.57
Forward PE	n/a
Dividend	0.14 (5.49%)
Ex-Dividend Date	Mar 27, 2026

Volume	2,690
Average Volume	14,842
Open	2.550
Previous Close	2.550
Day's Range	2.490 - 2.550
52-Week Range	1.700 - 2.840
Beta	0.57
RSI	44.28
Earnings Date	May 22, 2026

About Vita Life Sciences

Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China. The company offers various minerals, herbs, and superfoods. It markets its products through pharmacies and health food channels under the Herbs of Gold, VitaHealth, and VitaScience brands. The company was founded in 1947 and is headquartered in Mascot, Australia.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1947
• Employees: 350
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: VLS

Financial Performance

In 2025, Vita Life Sciences's revenue was 93.27 million, an increase of 17.31% compared to the previous year's 79.51 million. Earnings were 10.44 million, an increase of 18.80%.